MFE - Mcafee Profile, Stock Quotes, Financial Analysis, Charts, Fundamentals

United States Natural Gas Fund Lp announced financial time frame ending Mar 31 2021 operating profit of $19.888313 millions

For the financial time frame ending Mar 31 2021 United States Natural Gas Fund Lp turn a round at $0.41 per share, compared to results of $-4.48 per share a year ago quarter, In the previous quarter company realized $-1.52 per share.

Revenue turn positive from $-202.12 millions in preceding quarter, EPS turn positive from $-1.52 per share.

Income Positive Again,

For the first quarter of 2021 United States Oil Fund Lp earnings turn positive at $7.33 per share, compared to results of $-68.33 per share a year ago quarter, In the previous quarter company realized $3.55 per share.

Sales improved by 29.47 % from $562.24 millions in preceding quarter, eps more than doubled by 106.69 % from $3.55 per share.

Improvement in Profit Margins

Company delivered strong earnings growth on slow Sales increase in the fiscal period ending Mar 31 2021, where earnings per share more than doubled by 122.73 % at $4.41 per share, Sales grew modestly by 0.08% to $14.45 billions from the same quarter a year ago.

In comparison to previous quarter EPS turn positive from $-0.07 per share and Sales surged by 49.38 % from $9.68 billions.

Tal Education Group announced financial period ending Feb 28 2021 operating deficit of $-438.224 millions

Company increased losses at $-0.57 per share in the financial period ending Feb 28 2021, although its Sales surged by 37.35% to $4.50 billions from the same quarter a year ago.

In the previous quarter company realized Sales of $0.00 millions and $0.00 per share.
Tal Education Group reported net loss of $-143.05 millions and Sales of $4.50 billions for the fiscal year 2021.

Net loss per share has widen to $-0.57 from $-0.56 in previous fiscal year, while Sales surged by 37.35 % from $3.27 billions a year ago.

Twist Bioscience Corporation announced financial second quarter of 2021 operating deficit of $-38.004 millions

Twist Bioscience Corporation announced earnings per share of $-0.78 and Sales of $28.16 millions in the financial second quarter of 2021, Company's lost money per share, versus $-1.69 eps, earned in the same quarter a year ago, although Twist Bioscience Corporation saw its Sales rise by 81.8% in the same period.

In contrast to the first quarter Sales advanced by 10.81 % from $28.16 millions and increased losses from $-0.72 per share.

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar PODD's Profile Stock Price PODD's Financials Business Description Fundamentals Charts & Quotes PODD's News Suppliers PODD's Competitors Customers & Markets Economic Indicators PODD's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

MFE Company Profile

United States Natural Gas Fund Lp announced financial time frame ending Mar 31 2021 operating profit of $19.888313 millions

Income Positive Again,

Improvement in Profit Margins

Tal Education Group announced financial period ending Feb 28 2021 operating deficit of $-438.224 millions

Twist Bioscience Corporation announced financial second quarter of 2021 operating deficit of $-38.004 millions